ankylosing spondilitis |
181 |
familial mediterranean fever |
181, 256 |
mediterranean fever gene mutations |
181 |
ankylosing spondylitis |
191, 221, 231 |
inflammatory bowel disease |
191 |
metalloproteinase-3 |
191 |
metalloproteinase-9 |
191 |
tissue matrix metalloproteinase inhibitor-1 |
191 |
intra-articular injections |
198 |
knee osteoarthritis |
198 |
platelet rich plasma |
198 |
corticosteroid sparing |
206 |
glucocorticoid |
206 |
nonsteroidal anti-inflammatory drug |
206 |
tumor necrosis factor inhibitor |
206 |
rheumatoid arthritis |
206, 214, 231 |
atherosclerosis |
214 |
b-mode ultrasonography |
214 |
homocysteine |
214 |
cardiometabolic risk factors |
221 |
epicardial fat thickness |
221 |
autoimmune diseases |
226 |
prevalence |
226, 263 |
rheumatoid factor |
226 |
pain |
231 |
quality of life |
231 |
hereditary autoinflammatory disease |
244 |
hyperimmunoglobulin d syndrome |
244 |
mevalonate kinase mutation |
244 |
anti-tumor necrosis factor alpha therapy |
247 |
sapho syndrome |
247 |
spinal cord compression |
247 |
spondylodiscitis |
247 |
arthritis |
253 |
elbow |
253 |
lipoma arborescens |
253 |
magnetic resonance imaging |
253 |
synovectomy |
253 |
children |
256 |
pseudotumor cerebri |
256 |
extraglandular manifestations |
263 |
sjögren’s syndrome |
263 |